<VariationArchive VariationID="817418" VariationName="NM_025114.4(CEP290):c.2594_2595del (p.Leu865fs)" VariationType="Deletion" Accession="VCV000817418" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="3" DateLastUpdated="2024-03-05" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="805760" VariationID="817418">
      <GeneList>
        <Gene Symbol="CEP290" FullName="centrosomal protein 290" GeneID="80184" HGNC_ID="HGNC:29021" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="88049016" stop="88142088" display_start="88049016" display_stop="88142088" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="88442789" stop="88535992" display_start="88442789" display_stop="88535992" Strand="-" />
          </Location>
          <OMIM>610142</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025114.4(CEP290):c.2594_2595del (p.Leu865fs)</Name>
      <CanonicalSPDI>NC_000012.12:88106896:GAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q21.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="88106897" stop="88106898" display_start="88106897" display_stop="88106898" variantLength="2" positionVCF="88106896" referenceAlleleVCF="TGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="88500674" stop="88500675" display_start="88500674" display_stop="88500675" variantLength="2" positionVCF="88500673" referenceAlleleVCF="TGA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L865fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.88500675_88500676del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.88500675_88500676del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.88106898_88106899del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.88106898_88106899del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008417.2" sequenceAccession="NG_008417" sequenceVersion="2" change="g.40319_40320del">
            <Expression>NG_008417.2:g.40319_40320del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025114.4" sequenceAccession="NM_025114" sequenceVersion="4" change="c.2594_2595del" MANESelect="true">
            <Expression>NM_025114.4:c.2594_2595del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079390.3" sequenceAccession="NP_079390" sequenceVersion="3" change="p.Leu865fs">
            <Expression>NP_079390.3:p.Leu865fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_694" sequenceAccession="LRG_694">
            <Expression>LRG_694:g.40319_40320del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_694t1" sequenceAccession="LRG_694t1">
            <Expression>LRG_694t1:c.2594_2595del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_694p1" sequenceAccession="LRG_694p1" change="p.Leu865fs">
            <Expression>LRG_694p1:p.Leu865fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1221464366" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025114.4(CEP290):c.2594_2595del (p.Leu865fs) AND not provided" Accession="RCV001008546" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-25" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025114.4(CEP290):c.2594_2595del (p.Leu865fs) AND multiple conditions" Accession="RCV001384273" Version="4">
        <ClassifiedConditionList TraitSetID="22840">
          <ClassifiedCondition DB="MedGen" ID="C0431399">Familial aplasia of the vermis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0265215">Meckel-Gruber syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025114.4(CEP290):c.2594_2595del (p.Leu865fs) AND Joubert syndrome 5" Accession="RCV001330037" Version="1">
        <ClassifiedConditionList TraitSetID="359">
          <ClassifiedCondition DB="MedGen" ID="C1857780">Joubert syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-03-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025114.4(CEP290):c.2594_2595del (p.Leu865fs) AND Bardet-Biedl syndrome 14" Accession="RCV003467582" Version="1">
        <ClassifiedConditionList TraitSetID="363">
          <ClassifiedCondition DB="MedGen" ID="C2673874">Bardet-Biedl syndrome 14</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-16" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-01" NumberOfSubmissions="4" NumberOfSubmitters="3" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16909394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17345604</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20690115</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="22840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="2736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DYSENCEPHALIA SPLANCHNOCYSTICA</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gruber syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysencephalia splachnocystica</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Meckel-Gruber syndrome</ElementValue>
                <XRef ID="29076005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MKS</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MES</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3436" />
                <XRef ID="3436" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="564" DB="Orphanet" />
              <XRef ID="C0265215" DB="MedGen" />
              <XRef ID="MONDO:0018921" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS249000" DB="OMIM" />
            </Trait>
            <Trait ID="1878" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebelloparenchymal disorder 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Joubert-Boltshauser syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial aplasia of the vermis</ElementValue>
                <XRef ID="Familial+aplasia+of+the+vermis/8373" DB="Genetic Alliance" />
                <XRef ID="253175003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Joubert syndrome</ElementValue>
                <XRef ID="MONDO:0018772" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS213300" DB="OMIM" />
                <XRef ID="716997004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEREBELLOPARENCHYMAL DISORDER IV</ElementValue>
                <XRef Type="MIM" ID="213300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JBTS</ElementValue>
                <XRef Type="MIM" ID="213300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6802" />
                <XRef ID="6802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.</Attribute>
                <XRef ID="NBK1325" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301500</ID>
                <ID Source="BookShelf">NBK1325</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21448235</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="475" DB="Orphanet" />
              <XRef ID="C0431399" DB="MedGen" />
              <XRef ID="MONDO:0018772" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS213300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="359" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5350" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Joubert syndrome 5</ElementValue>
                <XRef ID="MONDO:0012432" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CEP290</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">JBTS5</ElementValue>
                <XRef Type="MIM" ID="610188" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.</Attribute>
                <XRef ID="NBK1325" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15475" />
                <XRef ID="15475" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301500</ID>
                <ID Source="BookShelf">NBK1325</ID>
              </Citation>
              <XRef ID="2318" DB="Orphanet" />
              <XRef ID="C1857780" DB="MedGen" />
              <XRef ID="MONDO:0012432" DB="MONDO" />
              <XRef Type="MIM" ID="610188" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="363" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8926" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bardet-Biedl syndrome 14</ElementValue>
                <XRef ID="MONDO:0014442" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BBS14</ElementValue>
                <XRef Type="MIM" ID="615991" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16038" />
                <XRef ID="16038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301537</ID>
                <ID Source="BookShelf">NBK1363</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2010">
                <ID Source="pmc">3061994</ID>
              </Citation>
              <XRef ID="110" DB="Orphanet" />
              <XRef ID="C2673874" DB="MedGen" />
              <XRef ID="MONDO:0014442" DB="MONDO" />
              <XRef Type="MIM" ID="615991" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2306312" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:2734246|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168319" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.2594_2595delTC variant in the CEP290 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.2594_2595delTC variant causes a frameshift starting with codon Leucine 865, changes this amino acid to a Glutamine residue, and creates a premature Stop codon at position 9 of the new reading frame, denoted p.Leu865GlnfsX9. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.2594_2595delTC variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.2594_2595delTC as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP290" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025114.3:c.2594_2595delTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2996843" SubmissionDate="2021-02-21" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_025114.3:c.2594_2595delTC|OMIM:610188" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001521628" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP290" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025114.3:c.2594_2595delTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610188" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9109035</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865580" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_025114.4:c.2594_2595del|OMIM:615991" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004216658" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025114.4:c.2594_2595del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615991" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3109349" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4390054|MedGen:C0431399;C0265215;C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583707" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16909394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17345604</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20690115</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu865Glnfs*9) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CEP290-related conditions. ClinVar contains an entry for this variant (Variation ID: 817418). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP290" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.88500674_88500675del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0431399" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265215" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3109349" TraitType="Disease" MappingType="XRef" MappingValue="C0265215" MappingRef="MedGen">
        <MedGen CUI="C0265215" Name="Meckel-Gruber syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2996843" TraitType="Disease" MappingType="XRef" MappingValue="610188" MappingRef="OMIM">
        <MedGen CUI="C1857780" Name="Joubert syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306312" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3109349" TraitType="Disease" MappingType="XRef" MappingValue="C0431399" MappingRef="MedGen">
        <MedGen CUI="C0431399" Name="Familial aplasia of the vermis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865580" TraitType="Disease" MappingType="XRef" MappingValue="615991" MappingRef="OMIM">
        <MedGen CUI="C2673874" Name="Bardet-Biedl syndrome 14" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3109349" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

